JP2016516449A5 - - Google Patents

Download PDF

Info

Publication number
JP2016516449A5
JP2016516449A5 JP2016512364A JP2016512364A JP2016516449A5 JP 2016516449 A5 JP2016516449 A5 JP 2016516449A5 JP 2016512364 A JP2016512364 A JP 2016512364A JP 2016512364 A JP2016512364 A JP 2016512364A JP 2016516449 A5 JP2016516449 A5 JP 2016516449A5
Authority
JP
Japan
Prior art keywords
sample
hla allele
maternal
exon
allele
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016512364A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016516449A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/059348 external-priority patent/WO2014180910A1/en
Publication of JP2016516449A publication Critical patent/JP2016516449A/ja
Publication of JP2016516449A5 publication Critical patent/JP2016516449A5/ja
Pending legal-status Critical Current

Links

JP2016512364A 2013-05-09 2014-05-07 Hlaマーカーを使用する母体血液中の胎児dna分率の決定方法 Pending JP2016516449A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361821620P 2013-05-09 2013-05-09
US61/821,620 2013-05-09
US201361861316P 2013-08-01 2013-08-01
US61/861,316 2013-08-01
PCT/EP2014/059348 WO2014180910A1 (en) 2013-05-09 2014-05-07 Method of determining the fraction of fetal dna in maternal blood using hla markers

Publications (2)

Publication Number Publication Date
JP2016516449A JP2016516449A (ja) 2016-06-09
JP2016516449A5 true JP2016516449A5 (enExample) 2017-06-08

Family

ID=50680043

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016512364A Pending JP2016516449A (ja) 2013-05-09 2014-05-07 Hlaマーカーを使用する母体血液中の胎児dna分率の決定方法

Country Status (6)

Country Link
US (1) US20150203914A1 (enExample)
EP (1) EP2994538A1 (enExample)
JP (1) JP2016516449A (enExample)
CN (1) CN105189787A (enExample)
CA (1) CA2909479A1 (enExample)
WO (1) WO2014180910A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10131947B2 (en) * 2011-01-25 2018-11-20 Ariosa Diagnostics, Inc. Noninvasive detection of fetal aneuploidy in egg donor pregnancies
PL3117012T5 (pl) 2014-03-14 2026-03-16 Caredx, Inc. Sposoby monitorowania terapii immunosupresyjnych u biorcy przeszczepu
CN108256296B (zh) * 2017-12-29 2021-05-25 北京科迅生物技术有限公司 数据处理装置
RU2681488C1 (ru) * 2018-04-19 2019-03-06 Федеральное государственное бюджетное образовательное учреждение дополнительного профессионального образования "Российская медицинская академия непрерывного профессионального образования" Министерства здравоохранения Российской Федерации Способ прогнозирования состояния плода человека накануне родов
MY205773A (en) * 2019-08-14 2024-11-12 Bgi Genomics Co Ltd Method and device for determining fetal nucleic acid concentration in maternal plasma
PL445283A1 (pl) * 2023-06-20 2024-12-23 Instytut Centrum Zdrowia Matki Polki Sposób nieinwazyjnej analizy płodowego DNA oraz frakcji płodu z wykorzystaniem reakcji multipleks digital PCR

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9620209D0 (en) 1996-09-27 1996-11-13 Cemu Bioteknik Ab Method of sequencing DNA
GB9626815D0 (en) 1996-12-23 1997-02-12 Cemu Bioteknik Ab Method of sequencing DNA
GB9704444D0 (en) 1997-03-04 1997-04-23 Isis Innovation Non-invasive prenatal diagnosis
US6274320B1 (en) 1999-09-16 2001-08-14 Curagen Corporation Method of sequencing a nucleic acid
EP1599608A4 (en) * 2003-03-05 2007-07-18 Genetic Technologies Ltd Identification of fetal DNA and fetal cell marker in maternal plasma or serum
US7867703B2 (en) 2004-08-26 2011-01-11 Agilent Technologies, Inc. Element defined sequence complexity reduction
US8383338B2 (en) 2006-04-24 2013-02-26 Roche Nimblegen, Inc. Methods and systems for uniform enrichment of genomic regions
US8262900B2 (en) 2006-12-14 2012-09-11 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US8315817B2 (en) 2007-01-26 2012-11-20 Illumina, Inc. Independently removable nucleic acid sequencing system and method
US7835871B2 (en) 2007-01-26 2010-11-16 Illumina, Inc. Nucleic acid sequencing system and method
EP2203567B1 (en) * 2007-10-16 2011-05-11 Roche Diagnostics GmbH High resolution, high throughput hla genotyping by clonal sequencing
US20100261189A1 (en) * 2008-10-03 2010-10-14 Roche Molecular Systems, Inc. System and method for detection of HLA Variants
LT3241914T (lt) * 2009-11-05 2019-04-25 The Chinese University Of Hong Kong Vaisiaus genomo analizė iš motinos biologinio mėginio
US8877442B2 (en) * 2010-12-07 2014-11-04 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive determination of fetal inheritance of parental haplotypes at the genome-wide scale

Similar Documents

Publication Publication Date Title
US12428682B2 (en) Methods for diagnosing infectious disease and determining HLA status using immune repertoire sequencing
Al-Mousa et al. Unbiased targeted next-generation sequencing molecular approach for primary immunodeficiency diseases
Grossen et al. Introgression from domestic goat generated variation at the major histocompatibility complex of Alpine ibex
Alcina et al. Multiple sclerosis risk variant HLA-DRB1* 1501 associates with high expression of DRB1 gene in different human populations
TWI801188B (zh) 藉由大量平行rna定序之母體血漿轉錄體分析
CN115917001A (zh) 用于检测供体源性游离dna的方法
Mero et al. Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles
US20150225789A1 (en) Haplotying of hla loci with ultra-deep shotgun sequencing
JP2014502845A5 (enExample)
WO2017156290A9 (en) A novel algorithm for smn1 and smn2 copy number analysis using coverage depth data from next generation sequencing
JP2014507141A5 (enExample)
CN103620055A (zh) 在全基因组规模非侵入性确定亲本单倍型的胎儿遗传
CN108604258A (zh) 染色体异常判断方法
JP2012507306A (ja) 核酸配列を調査するための手段および方法
WO2015042980A1 (zh) 确定染色体预定区域中snp信息的方法、系统和计算机可读介质
JP2013544536A5 (enExample)
Kumar et al. Tumor necrosis factor–associated susceptibility to type 1 diabetes is caused by linkage disequilibrium with HLA-DR3 haplotypes
US20150203914A1 (en) Method of determining the fraction of fetal dna in maternal blood using hla markers
WO2020047694A1 (zh) 确定新发突变在胚胎中的遗传状态的方法和装置
Mistry et al. Exome sequencing of 75 individuals from multiply affected coeliac families and large scale resequencing follow up
Díaz-Peña et al. Genetic study confirms association of HLA-DPA1∗ 01: 03 subtype with ankylosing spondylitis in HLA-B27-positive populations
CN116601714A (zh) 使用非错误传播定相技术和等位基因平衡的组合改进cnv检测
Geretz et al. Next-generation sequencing of 11 HLA loci in a large dengue vaccine cohort from the Philippines
CN104508141A (zh) 确定个体是否患有异常状态的方法及系统
Harding et al. Genotype–phenotype correlation for non-HLA disease associated risk alleles in multiple sclerosis